Papers

4

Total Citations

186

H-Index

3

About

Mieke Van Hemelrijck is a leading epidemiologist and health services researcher whose work bridges surgical oncology, patient-reported outcomes, and cognitive training in robotic surgery. Her major contributions center on optimizing treatment and recovery for muscle-invasive bladder cancer, particularly through the landmark CORAL trial, which provided the first long-term oncological outcomes comparing open, robotic, and laparoscopic radical cystectomy (116 citations). She has also pioneered the use of motor imagery—a form of cognitive training—to improve both technical and non-technical skills in minimally invasive surgery, as demonstrated in a randomized controlled trial (40 citations). Her umbrella review synthesizing health-related quality of life after various curative treatments for bladder cancer (28 citations) offers crucial guidance for shared decision-making. Van Hemelrijck’s work is distinguished by its rigorous trial design and patient-centered focus, directly informing surgical training and postoperative care. Her research has been widely cited and continues to shape evidence-based practice in urologic oncology and surgical education.

Research Focus

Key Achievements

3
H-Index
4
Papers
186
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Long-term Oncological Outcomes from an Early Phase Randomised Controlled Three-arm Trial of Open, Robotic, and Laparoscopic Radical Cystectomy (CORAL)
116 citations · 2019
📈 Most Prolific Year: 2018 (2 Papers)
🤝 Key Collaborators: 30
🏛 Institutions: King's College London, Center for Special Minimally Invasive and Robotic Surgery

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 16 days ago